Premium
P154: Elevated serum dipeptidyl peptidase 4 (DPP4) and interferon gamma inducible protein‐10 (IP‐10) levels demonstrated in obese patients with chronic hepatitis (CHC) potentially link obesity to unfavorable treatment response outcome
Publication year - 2015
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.142_12425
Subject(s) - chronic hepatitis , obesity , medicine , dipeptidyl peptidase , dipeptidyl peptidase 4 , correct name , interferon , immunology , gastroenterology , bioinformatics , endocrinology , biology , diabetes mellitus , type 2 diabetes , virus , biochemistry , enzyme , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom